Media

Filter by Category

All Blog News Podcasts Presentations Press Releases Publications Videos

Filter by Program

Filter by Publish Date

Global Biopharmaceutical Leader to Usher C-Path in Next Phase of Growth and Innovation

Board names Dr. Daniel Jorgensen as Chief Executive Officer TUCSON, Ariz., Sept. 27, 2022 — Critical Path Institute (C-Path) tod

Swingle joined C-Path in 2019 and was named interim president in 2021 TUCSON, Ariz., Sept. 8, 2022 — Critical Path Institute (C-

March 28, 2022

C-Path thanks and commends FDA for inviting public comments as part of the creation of a guidance document for Digital Health...

The Clinical Outcomes Assessment (COA), Critical Path for Parkinson’s Digital Drug Development (3DT) Initiative, and Type 1 Diab

March 18, 2022

Sensor data from digital health technologies (DHTs) used in clinical trials provides a valuable source of information...

March 18, 2022

Critical Path for Parkinson’s members, advisors and staff submitted six posters on behalf of CPP and CPP’s digital effort, Dig

January 11, 2022

Join 3DT and DiMe Society, January 11, to hear about 3DT recommendations for patient engagement. C-Path’s Critical Path for

Critical Path for Parkinson’s is proud to highlight Mikayla Spott who joined the team as CPP’s first consortium intern i

September 24, 2021

Recommendations for involving people with Parkinson’s in clinical studies using digital health tools

August 17, 2021

C-Path’s Neuroscience Program hosted its first webinar on August 17, 2021. This webinar brought together more than 330 members,